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The ability of stem cells to activate different
gene expression programs requires the choreo-
graphed assembly of trans-acting factors at
enhancers and promoters during cell differenti-
ation. In this study, we show that the pro-
teasome acts on specific regulatory regions in
embryonic stem (ES) cells to prevent incorrect
transcriptional initiation. Chemical or siRNA-
mediated inhibition of proteasome activity
results in increased transcription factor and
RNA polymerase II binding and leads to activa-
tion of cryptic promoters. Analysis of the bind-
ing profiles of different proteasome subunits
in normal ES cells and following RNAi knock-
down of individual subunits provides evidence
for a targeted assembly of the 26S proteasome
at specific regulatory elements. Our results sug-
gest that the proteasome promotes a dynamic
turnover of transcription factor and Pol II bind-
ing at tissue-specific gene domains in ES cells,
thereby restricting permissive transcriptional
activity and keeping the genes in a potentiated
state, ready for activation at later stages.
INTRODUCTION
Accurate developmental regulation of transcription is
critical for the establishment and maintenance of tissue-
specific gene expression patterns in higher eukaryotes.
Embryonic stem (ES) cells have the ability to activate all
somatic gene expression programs during their differenti-
ation into various lineages, and consequently they are
able to give rise to every cell type in the body. This
property, which is termed pluripotency, raises important
questions about how transcriptional competence ofCell 1lineage-specific genes is maintained at the ES cell stage.
There is evidence that in ES cells, tissue-specific genes
are primed for transcription at later stages of development
and that this is important for maintaining pluripotency
(Boyer et al., 2005; Szutorisz and Dillon, 2005). This
primed state is characterized by a generally hyperdynamic
state of ES cell chromatin (Meshorer and Misteli, 2006;
Perry et al., 2004). At the same time, localized regions of
active histone modifications form early transcription com-
petence marks (ETCMs) in ES cells, and these epigenetic
marks have been shown to act as centers for transcription
factor recruitment (Figure 1A) (Szutorisz et al., 2005a).
Chromatin modification, general transcription factor
(GTF) recruitment, and preinitiation complex (PIC) assem-
bly are key control points for regulating transcription,
because they specify where and at which time point
RNA polymerase II (Pol II) transcription will be initiated.
Site- and stage-specific control of PIC formation presents
a particular problem in the permissive chromatin environ-
ment of ES cells. In fact, PIC assembly has been shown to
be restricted to specific regulatory elements, colocalizing
with the ETCM regions (Szutorisz et al., 2005b). These ob-
servations suggest that there aremechanisms that restrict
nonspecific transcription factor binding in undifferentiated
cells.
The proteasome has recently been implicated in the dy-
namic control of factor binding to transcriptionally active
promoters (Collins and Tansey, 2006). The 26S protea-
some is a highly conserved protease that plays a central
role in the control of protein stability in eukaryotic cells.
The 26S proteasomal complex is organized into two sub-
complexes, the 20S proteolytic core and the 19S regula-
tory particle (Figure 1B). The 20S core is composed of
four rings of a-type and b-type subunits with the two inner
b rings having proteolytic activity (Groll et al., 2005). The
19S complex is divided into two components, the base
and the lid. The base contains ATPases and nonenzymatic
subunits, whereas the proteins that form the lid are
thought to be responsible for substrate recognition (Pick-
art and Cohen, 2004).27, 1375–1388, December 29, 2006 ª2006 Elsevier Inc. 1375
Figure 1. Proteasome Inhibition Results in Increased Transcript Levels at the l5-VpreB1 Locus in ES Cells
(A) The murine l5-VpreB1 locus. The Topo3b gene is expressed ubiquitously. Black and white boxes are exons and introns, respectively. Vertical
arrows show positions of the 12 previously mapped DNase I hypersensitive sites (HS). Enh, enhancer; ETCM, early transcription competence mark.
(B) The 26S proteasome. The core (20S) is composed of two identical rings of a and b subunits. Regulatory particle (19S): base (light green) and lid
(dark green).
(C) Effect of MG132 treatment on transcript levels. Transcript levels were measured by Q-RT-PCR at 2 hr intervals and relative changes are shown in
the plots as ratios betweenMG132-treated and -untreated cells. Y axes, fold change in transcript levels relative to untreated cells. X axes, time points
of MG132 treatment and negative controls without reverse transcriptase (). Error bars are propagated standard deviations from two to three
independent experiments. Orange squares show positions of PCR amplicons. Red horizontal bar in the locus map shows location of the intergenic
enhancer.
(D) Effect of proteasome inhibition on spliced l5 mRNA; measurement and error bars as in panel (C).There is evidence that the proteasome is involved in two
different types of mechanism for regulating active pro-
moters. One of these functions depends on the proteolytic
activity of the 20S proteasome, which facilitates transcrip-
tional elongation bymediating turnover of promoter bound
activators and allowing the initiating RNA polymerase to1376 Cell 127, 1375–1388, December 29, 2006 ª2006 Elsevier Inescape from the promoter (Lipford et al., 2005; Muratani
et al., 2005; Perissi and Rosenfeld, 2005). Recent studies
have also identified a second function for the 19S com-
plex, which has been proposed to modulate factor
recruitment independently of the 20S core by inducing
conformational changes in the targeted proteins (Ferdousc.
et al., 2001; Lee et al., 2005; Metivier et al., 2003). These
studies highlight the involvement of the proteasome in
the regulation of transcription at fully active genes.
Here we show that proteolytic degradation by the pro-
teasome has a previously undescribed role in controlling
transcription factor binding to regulatory regions of cell
type-specific gene domains in ES cells. At the pluripotent
stage, where tissue-specific gene loci are maintained in
a state that is competent for future expression but are still
inactive, stable binding of transcription factors and Pol II
to specific sequence elements is suppressed by the activ-
ity of the proteasome. This mechanism involves direct
targeting of the proteasome to intergenic sequences and
restricts permissive transcription in ES cells.
RESULTS
Proteasome Inhibition Results in Increased Levels
of Intergenic Transcription in a Tissue-Specific
Locus in ES Cells
We hypothesized that turnover of transcription factor
binding at tissue-specific genes might be a key element
that would contribute to maintenance of ES cell pluripo-
tency. Removal of initiation complexes by the proteasome
would be a potential mechanism for restricting transcrip-
tional activity in permissive chromatin. To test this hypoth-
esis, we examined the effect of chemical inhibition of
proteasome activity on transcription of a tissue-specific
locus in mouse embryonic stem cells. The VpreB1 and
l5 genes (Figure 1A) are activated during the early stages
of B cell development under the control of a multicompo-
nent locus control region (LCR); they are fully expressed in
pre-B cells and silent in mature B cells (Sabbattini and
Dillon, 2005). Low-level, permissive transcription is also
detectable in the locus in ES cells (Szutorisz et al., 2005a).
To determine whether transcriptional activity of the
l5-VpreB1 locus in pluripotent stem cells is controlled
by the proteasome, ES cells were treated with inhibitors
that block the proteolytic activity of the 20S core. The ef-
fect of proteasome inhibition on transcript levels at differ-
ent regions in the locus was analyzed in ES cells and was
compared with the effect on the active locus in pre-B cells
and in mature B cells where the locus is silenced (Fig-
ure 1C). Cells were treated with the proteasome inhibitor
MG132, and changes in transcript levels were measured
by quantitative real-time RT-PCR (Q-RT-PCR) during
a 10 hr time course. Propidium-iodide- (PI) staining fol-
lowed by FACS analysis showed that an 8 hr incubation
in 20 mM MG132 did not substantially affect cell survival
(Figure S1A). No significant morphological changes were
observed in the cultures (Figure S1B), and FACS analysis
of Oct-4 expression confirmed that short-term protea-
some inhibition did not lead to ES cell differentiation (Fig-
ure S1C). Because we were primarily interested in the
functioning of regulatory elements and it is known that in-
creased noncoding RNA transcription can be a hallmark of
PIC assembly, the analysis focused mainly on the gene
promoters and intergenic regulatory sequences.Cell 1A dramatic increase in transcript level was observed in
ES cells only andwas restricted to two regions of the locus
(Figure 1C, values are shown as relative differences). One
of the sites of increased transcription corresponds to an
intergenic element that has been shown to have enhancer
activity at the pre-B cell stage (Minaee et al., 2005). The
second affected region extends from the l5 promoter
into the l5 gene and includes both introns (Figure 1C, bot-
tom panel). A small increase was also detected in the
introns of the l5 gene in mature B cells but not at the inter-
genic element. No significant change was found in the
active locus in pre-B cells. Treatment with a different
proteasome inhibitor (lactacystine) resulted in a similar
pattern of increased transcription in ES cells (Figure S2A).
Control treatments with the protease inhibitor leupeptin
and the lysosome inhibitor ammonium-chloride did not
lead to any increase in transcription (Figure S2B). No in-
crease in transcript levels was detected when primers
that amplify spliced l5 RNA (spanning the second intron
of the gene) were used (Figure 1D), indicating that the in-
duced transcripts are not properly processed or initiated
from themain transcription start site (TSS). It is particularly
interesting that one of the regions where transcription is
affected by proteasome inhibition in ES cells colocalizes
with the ETCM, which is a center for factor binding during
cell differentiation. As the l5-VpreB1 genes are activated
during commitment to the B cell lineage, the chromatin
in the ETCM region undergoes remodeling and the result-
ing local accessibility is reflected in the early appearance
of two DNase I hypersensitive sites, HS7 and HS8 (Szutor-
isz et al., 2005a).
Increased Transcription of the Intergenic Region
following RNAi-Mediated Knockdown of
Individual Core Proteasome Subunits
Increased transcript levels after chemical inhibition sug-
gest the involvement of the 20S core proteasome. To dis-
sect the role of individual subunits, expression of two core
subunits was knocked down using siRNAs. ES cells were
transfected with siRNAs against either the b4 or the b7
subunits, and the effect was monitored at 4 hr intervals
(Figure 2A). Specificity of the knockdown was demon-
strated by the fact that there was no significant change
in TATA binding protein (TBP) levels and by transfection
with control siRNAs against GAPDH. Transfection with
the b4 or b7 siRNAs slowed the growth of the cells at
late time points (Figure S3A), similar to the effect of chem-
ical inhibition.
Knock-down of either the b4 or b7 subunit of the 20S
proteasome resulted in a highly specific increase in tran-
scripts in the intergenic region (Figure 2B), confirming
the effect that was observed using chemical inhibitors.
The slightly different timing of the increase might be due
to differential physiological responses of the cells to the
loss of distinct proteasome subunits, affecting, e.g., tran-
scription rate or RNA stability at the 38 hr time point. It is
notable that, compared to chemical inhibition, the pro-
moter region of the l5 gene was less dramatically affected27, 1375–1388, December 29, 2006 ª2006 Elsevier Inc. 1377
Figure 2. RNAi-Mediated Knockdown of Core Proteasome Subunits Results in Increased Intergenic Transcription in ES Cells
(A) Knockdown of the b4 and b7 subunits. Protein levels were analyzed by western blotting at different time points after transfection with siRNAs.
Controls using nonspecific siRNAs (Ctrl) and knockdown of GAPDH showed no effect on the expression of proteasome subunits. TBP, loading
control.
(B) Effect of b4 and b7 knockdown on transcripts relative to ES cells transfected with control siRNAs. See legend to Figure 1C for details of quanti-
fication. Error bars are propagated standard deviations from two independent transfections. X axes, time (hr) posttransfection and no RT controls ().
Analysis of MLN51 mRNA shows no effect of proteasome knockdown on transcription of a ubiquitously expressed gene.by the specific knockdown of the b4 and b7 subunits
(compare Figures 1C and 2B). Together with the strong
induction at the HS7/8 enhancer after specific knockdown
of 20S proteasome proteins, this suggests that there
could be site-specific recruitment of different proteasome
subunits.
Proteasome Inhibition in ES Cells Triggers
the Activation of Intergenic Promoters
Two explanations can be put forward to explain the
change in transcriptional activity in the intergenic region
following proteasome inhibition. One possibility is that
there is an increased transcription rate that might involve
more frequent reinitiation cycles from already active pro-
moters due to lower turnover of activator binding. The
other potential explanation is de novo activation of previ-
ously inactive promoters, and this would be reflected in
the appearance of new initiation sites.
In order to investigate whether proteasome inhibition
leads to new initiation events in ES cells, transcription start
sites in the l5-VpreB1 locus were mapped by 50 RACE1378 Cell 127, 1375–1388, December 29, 2006 ª2006 Elsevier Infollowing proteasome inhibition (strategy is shown in Fig-
ure S4A). RACE-PCR products were cloned and se-
quenced to determine the 50 ends. The location of the tran-
scription start sites is shown in Figure 3A. Consistent with
our previous analysis (Szutorisz et al., 2005a), transcripts
that initiated correctly from the main l5 TSS were not
found in untreated ES cells, and a cluster of antisense
(opposite direction to the l5 gene) transcripts in the
ETCM/HS8 region was observed.
A number of new initiation sites were identified following
inhibition of proteasome activity (Figures 3A and S4B). The
most prominent group of start sites (transcribing in the
sense direction) was found within an 800 bp region be-
tween HS7 and the l5 promoter. No initiation sites were
observed in this region in untreated cells. Another tightly
localized cluster of antisense start sites was identified in
the HS8 region. There was also a significant change in
the pattern of initiation at HS8with the 50 ends reorganized
into a single, discrete cluster. Transcription start sites
were not detected in the HS7 region. Instead, de novo
initiation events were found upstream and downstreamc.
Figure 3. The ProteasomeSuppresses Transcription Initiation andControls Factor Binding in Intergenic Regulatory Regions at the
l5-VpreB1 Locus
(A) Proteasome inhibition generates de novo initiation events in ES cells (mapped by 50 RACE). Horizontal arrowheads show location of initiation sites
in untreated (No inh.) and inhibitor-treated (+Prot. inh.) ES cells. Direction of the transcripts is represented by direction of the arrowheads. Green line
shows l5 minimal promoter. Red and orange lines show enhancer. ETCM, early transcription competence mark.
(B) Increased factor binding following proteasome inhibition in ES cells. ChIP plots of factor binding show the relative change of occupancy of different
regions following proteasome inhibition. Y axes, fold difference in binding level. Increased binding is observed when the detected signal is >1 (above
the grey horizontal bars). Orange squares, positions of PCR amplicons. Error bars are propagated standard deviations between two to three inde-
pendent experiments.
(C and D) Effect of proteasome inhibition on factor binding in differentiated cells. Analysis and error bars as in panel (A).
(E) Levels of Pol II, TBP, and Brg1 in untreated and MG132-treated ES cells analyzed by western blotting. Analysis of polyubiquitylated proteins and
Mdm2 was used to monitor proteasome inhibition (Stommel and Wahl, 2005).
(F) Reporter constructs. P, construct containing the l5 promoter (green box) and the b-globin gene (black box). P + E: enhancer-containing construct.
(G) Effect of the HS7/8 region on transcription in ES cells. Transcript levels were measured by Q-RT-PCR 2 days after transfection with the reporter
construct. Mock: untransfected ES cells. Error bars are standard deviations between two transfections.Cell 127, 1375–1388, December 29, 2006 ª2006 Elsevier Inc. 1379
of HS7, resulting in bidirectional transcription. These
results could be explained by the presence of a strong
bidirectional promoter in the HS7/8 region, which is sup-
pressed by the proteasome in ES cells. The third cluster
of start sites (transcribing in the sense direction) was
detected in the first exon and intron of the l5 gene. The
pattern of initiation sites described above is consistent
with the effect of proteasome inhibition on transcript levels
(Figure 1C).
Induction of Transcription following Proteasome
Inhibition Correlates with Increased Factor
Binding to the Intergenic Regulatory Region
The finding that proteasome inhibition gives rise to new in-
tergenic transcription initiation sites in ES cells suggested
that the proteasomemight be involved in suppressing pre-
initiation complex formation. To investigate this hypothe-
sis, the binding profile of several initiation factors was an-
alyzed by chromatin immunoprecipitation (ChIP). The TBP
and TBP-associated factors 5 and 10 (TAF5 and TAF10)
can be components of the TFIID or the TBP-free TAF-
containing (TFTC) complexes (Muller and Tora, 2004).
Transformation-transactivation-domain-associated pro-
tein (TRRAP) is a coactivator in different histone acetyl-
transferase (HAT) complexes (Frank et al., 2003; Liu
et al., 2003b). Brg1 is a subunit of the SWI/SNF ATP-
dependent chromatin-remodeling complex (Muchardt
and Yaniv, 2001). All of these factors are expressed ubiq-
uitously (Figure S5A) and are known to play important
roles in the assembly of PICs.
The results obtained for untreated cells are shown in
Figure S5. Consistent with our previous results, the main
sites of Pol II binding in ES cells are at the promoter of
the Topo3b gene and in the intergenic region between
the VpreB1 and l5 genes (Figure S5B). In pre-B cells, the
active l5-VpreB1 domain is characterized by high-level,
locus-wide transcription factor binding (Szutorisz et al.,
2005a). In mature B cells, where the VpreB1 and l5 genes
are silent, some Brg1, TAF10, and Pol II binding was still
detectable in the locus (Figure S5D).
Inhibitor treatment results in three types of specific ef-
fects. Firstly, binding of factors to the l5-VpreB1 locus is
increased by proteasome inhibition only in ES cells
(Figure 3B) andmature B cells (Figure 3D) where the genes
are inactive. Proteasome inhibition resulted in increased
binding of TBP, TRRAP, Brg1, and Pol II in these cell types.
Binding was not significantly affected in pre-B cells, where
transcription of the VpreB1 and l5 genes is fully active
(Figure 3C). Secondly, it is only in ES cells that increased
Pol II binding is detected in the locus, consistent with
the observation that proteasome inhibition at the ES cell
stage results in elevated transcript levels in the intergenic
region (Figures 1C and 2B). The third feature of the effect
of proteasome inhibition on factor binding and transcrip-
tion is the localization of much of the increased binding
of TBP, Brg1, TRRAP, and Pol II to the intergenic region
between the VpreB1 and l5 genes in ES cells.1380 Cell 127, 1375–1388, December 29, 2006 ª2006 Elsevier IOne possible explanation for the increased binding of
factors in ES cells would be a globally higher protein level
in the cell due to proteasome inhibition. MG132-treatment
results in accumulation of polyubiquitylated proteins and
an increase in the level of Mdm2, which is known to be
a target for the proteasome (Figure 3E). However, western
blot analysis of extracts from MG132-treated ES cells
showed no significant increase in Brg1, TBP, and Pol II
levels (Figure 3E). This, together with the fact that in-
creased binding was only observed at some sites (Fig-
ure 3B), indicates that proteasome inhibition affects
specific binding rather than global stability of these factors
in ES cells. In mature B cells, where the l5-VpreB1 locus is
silenced, levels of Pol II binding (Figure 3D) and transcrip-
tion (Figure 1C) showed only a very modest change,
despite the presence of increased TBP and TRRAP bind-
ing. This could be a consequence of a less accessible
chromatin structure and the binding of tissue-specific re-
pressors in differentiated cells.
We were interested in establishing whether the HS7/8
region might be able to affect transcription of other se-
quences in the locus at the ES cell stage. To test the effect
of the HS7/8 fragment on transcription, the fragment was
inserted upstreamof the l5promoter linked to a promoter-
less human b-globin gene (Figure 3F) and analyzed by
transient transfection of ES cells (Figure 3G). The l5 pro-
moter-reporter construct was expressed at low levels in
ES cells, and insertion of the HS7/8 fragment resulted in
a greater than 6-fold increase in reporter transcription.
RACE analysis of 50 ends showed that the transcripts ini-
tiate from the b-globin gene and not from the HS7/8 region
(data not shown). These results suggest that the HS7/8
fragment contains positive regulatory sequences that
can influence transcriptional activity of other regions of
the locus in ES cells.
Subunits of the 20S and 19S Proteasome
Are Recruited to the Intergenic Region
Site-specific regulation of transcription by the proteasome
raises the question of how the proteasome targets the
affected regions in ES cells. To address this question,
ChIP analysis was carried out to investigate the binding
of different 20S and 19S subunits to the intergenic region
of the l5-VpreB1 locus. The 20S core complex subunits
a4, b4, and b6 and the 19S proteasome subunits Rpt6
and Rpn12 were chosen for analysis. Rpt6 is an ATPase
that is located in the base of the 19S particle and has
been linked to proteolysis-independent transcriptional
regulation (Figure 1B). Rpn12 is a nonenzymatic compo-
nent of the lid, which has been suggested to participate
in substrate recognition (Figure 1B) (Wilkinson et al.,
2000). All five proteasome subunits are expressed at equal
levels in ES cells and differentiated cell types (Figure 4A).
In the absence of proteasome inhibition, binding of the
20S subunit a4was observed in the region of the enhancer
where HS7 forms at later stages of B cell development
(Figure 4B, left). Lower levels of a4 and b4 occupancy
were found in the HS8 region. No significant binding ofnc.
Figure 4. Proteasome Subunits Are Recruited to the Intergenic Region of the l5-VpreB1 Locus
(A) Expression of proteasome subunits measured by western blotting. Loading control: TBP, Lamin.
(B) Analysis of proteasome subunit recruitment in ES cells, measured by ChIP. Untreated cells (left panel): the signals were normalized to those ob-
tained from nonspecific IPs to define a background level (gray horizontal bar). Proteasome inhibitor-treated cells (right panel): analysis as in Figure 3B.
Error bars in the left panel are standard deviations from two to three experiments; in the right panel, propagated standard deviations are from two to
three experiments. Other symbols as in Figure 3B.
(C) Proteasome subunit binding following knockdown of b4, measured by ChIP. ES cells were transfected with siRNA targeted to the b4 core pro-
teasome subunit and treated with MG132 (top). Analysis and error bars as in panel (B).
(D) Knockdown of the Rpn12 lid subunit in ES cells. Analysis as in Figure 2A.
(E) Effect of Rpn12 knockdown on transcript levels relative to ES cells transfected with control siRNAs. Analysis as in Figure 2B. Error bars are prop-
agated standard deviations from two experiments.
(F) ChIP analysis of proteasome subunit binding following knockdown of Rpn12. ES cells were transfectedwith siRNAs targeted at the Rpn12 subunit.
Analysis and error bars as in panel (C).Cell 127, 1375–1388, December 29, 2006 ª2006 Elsevier Inc. 1381
19S subunits was detectable under these conditions.
When ES cells were treated with proteasome inhibitor
(Figure 4B, right), no increase was detected for a4 and
b4, suggesting a relatively stable binding of these pro-
teins, but a large increase in the binding of the core subunit
b6 and the lid subunit Rpn12 was observed with the big-
gest difference detected in the HS7 region (Figure 4B,
right). This dramatic increase indicates a highly dynamic
regulation of recruitment and release of b6 and Rpn12
that depends on proteasome activity. Comparison of pro-
teasome subunit binding in ES cells and differentiated
cells showed that the recruitment of the proteasome to
regulatory regions is a specific feature of ES cells (Fig-
ure S6). These data lead us to conclude that the control
of transcription factor binding at a tissue-specific locus
in ES cells involves direct recruitment of proteasome sub-
units to the sites where regulation occurs.
The 26S Proteasome Is Assembled at the Targeted
Sequences through Recruitment of Different
Subunits or Subcomplexes
It is particularly interesting that a4 and b4 binding to the in-
tergenic region is observed in ES cells in the absence of
proteasome inhibition, whereas significant b6 and Rpn12
occupancy is only detectable when proteasome activity
is inhibited. Thesedistinct binding profiles suggest a differ-
ential control of recruitment of proteasome subunits or
subcomplexes to intergenic regulatory regions. To test
this hypothesis, siRNA-mediated knockdown of individual
components of the proteasome was combined with ChIP
analysis of different subunits (Figure 4C). ES cells were
transfected with siRNA targeted to the b4 core subunit.
Following 26 hr of incubation, the proteasome inhibitor
MG132was added to half of the transfected ES cells. After
an additional 8 hr, the cells were harvested and the binding
pattern of proteasome subunits was analyzed by ChIP.
Knockdown of b4 resulted in a substantial reduction in
the binding of the 20S proteasome subunit a4 in the ab-
sence of proteasome inhibition. b4 knockdown also abol-
ished the binding of b6 that is observed following chemical
proteasome inhibition. These data suggest a cooperation
between different subunits of the core complex in the as-
sembly of the 20S proteasome at the targeted region. In
addition, knockdown of b4 resulted in an altered profile
of Rpn12 occupancy after MG132 treatment. Rpn12 bind-
ing was completely lost from the l5 promoter region and
reduced at HS7, but no significant change was detected
at HS8, suggesting that Rpn12 can be recruited to the
HS8 region independently of the binding of the core pro-
teasome. These results point to the existence of two dif-
ferent types of targeting, as follows: (1) Rpn12 recruitment
downstream of HS8 that depends on the binding of core
proteasome subunits and (2) a core subunit-independent
recruitment of an Rpn12-containing subcomplex to the
HS8 region. It is notable that HS8 is also a center for
GTF and Pol II recruitment in ES cells, suggesting that at
least some Rpn12 binding to HS8 might be associated
with the formation of the PIC.1382 Cell 127, 1375–1388, December 29, 2006 ª2006 Elsevier InTo gain a better insight into the role of Rpn12 in the
recruitment of the proteasome to the intergenic region,
we used siRNA to directly target Rpn12 expression (Fig-
ure 4D). Knockdown of Rpn12 slowed down ES cell
growth (Figure S3B) and resulted in increased levels of
intergenic transcripts in the HS8 enhancer region (Fig-
ure 4E), similar to the effects that were observed following
chemical proteasome inhibition and knockdown of 20S
proteasome subunits (compare Figures 1 and 2 with Fig-
ure 4E). The ChIP analysis (Figure 4F) showed that knock-
down of Rpn12 abolished binding of a4 and also blocked
the increase in b6 recruitment under conditions of protea-
some inhibition. These data suggest that Rpn12 is part of
the proteasomal complex that plays a critical role in sup-
pressing permissive transcription in ES cells.
The cooperation of the 20S proteasomewith the lid sub-
unit Rpn12 in this mechanism raises additional questions
about the involvement of other subunits of the 19S com-
plex in the regulation of permissive transcription. There-
fore, we tested whether ATPases, which are located in
the base of the 19S proteasome (Figure 1B), also partici-
pate in assembly of the proteasomal complex and sup-
pression of intergenic transcription by targeting expres-
sion of one of the ATPases, Rpt3 (Figures 5A and S3C).
Knockdown of Rpt3 again showed increased levels of in-
tergenic transcripts (Figure 5B). Interestingly, binding of
the a4 core proteasome subunit was not abolished, but
an altered binding pattern was observed (compare Fig-
ures 4B and 5C). While in normal ES cells the main site
of a4 recruitment was HS7, after Rpt3 knockdown, a
high level of binding is also detected at HS8. These obser-
vations suggest that the a4 subunit is recruited to the inter-
genic region independently of the Rpt3 ATPase and that
a reduced level of Rpt3 in ES cells leads to changes in
the recognition of different regions by an a4-containing
subcomplex. In addition, Rpt3 knockdown blocked the
large increase in b6 and Rpn12 binding that is seen
when the proteasome activity is inhibited (Figure 5C).
The effect of the Rpt3 knockdown also emphasizes the
similarity in the regulation of b6 and Rpn12 binding (com-
pare Figures 4B and 5C) and suggests that ATPase com-
ponents of the 19S particle are likely to control the turn-
over of proteasome assembly at the targeted elements.
The Proteasome Controls GTF Binding
and Transcriptional Activity at Different
Tissue-Specific Gene Loci
Our results suggest that proteasome-mediated suppres-
sion of factor binding could be a general mechanism for
controlling transcription. To investigate this possibility,
we analyzed the effects of proteasome inhibition on two
additional, well-characterized tissue-specific gene loci
(b-globin and HoxD4, Figure 6). Activation of the genes
of the mouse b-globin locus during erythroid development
is regulated by the LCR (Figure 6A), and an enhancer ele-
ment colocalizing with DNase hypersensitive site 2 (HS2)
of the LCR has been shown to be amajor site for transcrip-
tion factor recruitment (Vieira et al., 2004). The mousec.
Figure 5. Proteasome Assembly at Cryptic Promoters Involves an ATPase Subunit Located in the 19S Regulatory Particle
(A) Knockdown of the Rpt3 base ATPase subunit in ES cells. Analysis as in Figure 2A.
(B) Effect of Rpt3 knockdown on transcript levels relative to ES cells transfected with control siRNAs. Analysis as in Figure 2B. Error bars are prop-
agated standard deviations from two experiments.
(C) ChIP analysis of proteasome subunit binding following knockdown of Rpt3. ES cells were transfected with siRNAs targeted at the Rpt3 subunit.
Analysis as in Figure 4C. In the left panel, standard deviations are from two to three experiments. In the right panel, propagated standard deviations
are from two to three experiments.HoxD4 gene is expressed in neurons under the control of
an enhancer located 30 of the gene (Figure 6B) (Rastegar
et al., 2004). The common feature of all three domains
that have been investigated in this study is that their regu-
lation involves the formation of a localized GTF recruit-
ment center in regulatory regions during the early stages
of development (Szutorisz et al., 2005b).
In the b-globin locus, MG132-treatment resulted in in-
creased levels of Pol II and TBP binding with the most
prominent increase observed in the HS2 enhancer region
(Figure 6C, top panel, left). This correlates with elevated
transcript levels at HS2 (Figure 6C, bottom panel, left).
The HS2 region in the b-globin locus is not only the princi-
pal early stage-specific GTF recruitment center but also
contains a major cluster of noncoding RNA transcription
start sites (Routledge and Proudfoot, 2002) suggesting
a functional similarity to HS8 in the l5-VpreB1 locus. In
the HoxD4 locus, increased TBP and Pol II binding (Fig-
ure 6C, top panel, right) and a modest induction of tran-
scription (Figure 6C, bottom panel, right) was detected
at the 30 enhancer following proteasome inhibition.
Lastly, we examined the binding profiles of the a4, b6
and Rpn12 proteasome subunits at the b-globin and the
HoxD4 loci. In untreated ES cells (Figure 6D), only binding
of a4 was observed, with the highest level found at the
HS2 enhancer in the b-globin locus. Following protea-
some inhibition, increased binding of a4, b6, and Rpn12
was detected in regulatory regions of the b-globin andCell 1the HoxD4 loci (Figure 6E). The observed binding charac-
teristics of Rpn12 closely resemble the profile that was
seen in the l5-VpreB1 locus (see Figure 4B). Taken to-
gether, the data from three different domains suggest
a widespread involvement of the proteasome in the con-
trol of GTF binding and transcription at regulatory regions
of tissue-specific gene loci in ES cells.
DISCUSSION
The data from this study identify an entirely new function
for the proteasome as a transcriptional silencer that
blocks nonspecific transcription initiation in intergenic
and intragenic regions in ES cells through a mechanism
that depends on the proteolytic activity of the 20S core
(Figure 7). The effects of the proteasome on transcription
that have been identified to date relate to gene activation.
In addition to the nonproteolytic roles of the 19S regulatory
particle (see Introduction), previous studies in yeast (Lip-
ford et al., 2005; Muratani et al., 2005) and mammalian
cells (Kang et al., 2002; Reid et al., 2003) have established
that the proteolytic activity of the proteasome plays a crit-
ical role in the initiation and elongation stages of transcrip-
tion and also removes stalled Pol II from coding regions
and the 30 ends of active genes to facilitate the termination
of transcription (Gillette et al., 2004; Somesh et al., 2005).
Our results provide evidence that the proteolytic activity of
the proteasome silences permissive transcription in ES27, 1375–1388, December 29, 2006 ª2006 Elsevier Inc. 1383
Figure 6. The Proteasome Controls Factor Binding and Transcriptional Activity at Regulatory Elements of Different Tissue-
Specific Loci in ES Cells
(A) The mouse b-globin locus. LCR, locus control region. Vertical arrows show positions of HS. Enh, enhancer.
(B) The mouse HoxD4 locus. Enh, enhancer.
(C) Effect of proteasome inhibition on factor binding and transcription at regulatory regions of the b-globin andHoxD4 loci in ES cells. Panels above the
locus maps show relative increase in factor binding measured by ChIP. Panels below the loci show relative increase in transcript levels. Analysis and
symbols as in Figures 1C (transcription) and 3B (ChIP). Error bars are propagated standard deviations from two to three experiments.
(D) ChIP analysis of proteasome subunit binding in untreated ES cells. Analysis as in Figure 4B. Error bars are standard deviations from two to three
experiments.
(E) Effect of proteasome inhibition on proteasome subunit bindingmeasured byChIP. Analysis and symbols as in Figure 4B. Error bars are propagated
standard deviations from two to three experiments.cells by removing factors from their target sequences and
preventing PIC formation.
What allows the proteasome to have these different
effects? The extensively characterized stimulatory effect
of the proteasome on gene transcription is mediated by
specific interactions between proteasome subunits and
transcription factors (Collins and Tansey, 2006). The dis-
tinction between this type of activating function of the
proteasome at gene promoters and the silencing effect
on intergenic transcription that we observe in ES cells
might be due to differences in the regulation of pro-
moter-specific and nonspecific initiation events (Carrozza
et al., 2005). Specificity of transcriptional initiation is con-
trolled by activators that play key roles not only in the
targeting of the basal transcription machinery but also in
stabilizing the initiation complexes at promoters (Black
et al., 2006; Yudkovsky et al., 2000).1384 Cell 127, 1375–1388, December 29, 2006 ª2006 Elsevier IThe nonspecific, intergenic, and intragenic transcrip-
tion that is observed in ES cells occurs in a highly
accessible chromatin context in the absence of tissue-
specific activators. We speculate that this leads to
formation of incomplete PICs in intergenic regulatory
regions of tissue-specific gene domains that have an
altered conformation and composition compared to
‘‘normal’’ PICs, which are stabilized by activators (Fig-
ure 7). The abnormal structure of nonspecifically assem-
bled PICs would make these complexes or some of
their subunits targets for proteasomal degradation
(Asher et al., 2006). There is a growing body of evidence
that incorrectly folded proteins are subject to proteolysis
by a variant 20S core complex, which can target sub-
strates even in the absence of ATP and ubiquitylation
(Baugh and Pilipenko, 2004; Li et al., 2006; Liu et al.,
2003a).nc.
Figure 7. Model for the Control of Tran-
scription by the Proteasome in ES Cells
(A) Dynamic assembly of the proteasome at
intergenic regulatory elements. Proteasomal
subcomplexes are recruited to two different
types of PIC (step 1). A 19S subcomplex would
facilitate the formation of productive initiation
complexes recruited to the ETCM region by
a sequence-specific activator (PIC I). PICs as-
sembled on cryptic promoters in the absence
of an activator (PIC II) are targeted both by
the 20S core complex and the 19S regulatory
particle. Here, the 19S and 20S particles are
assembled into a functional 26S proteasome,
which removes PICs, thereby suppressing
permissive transcription (step 2). Our data are
consistent with a model of controlled cycles
of assembly/disassembly of the 26S protea-
some during proteolytic degradation of PIC
components (step 3). Curved arrows show dy-
namic exchange of proteasome subunits b6
and Rpn12. PIC, preinitiation complex; Act, ac-
tivator; ETCM, early transcription competence
mark.
(B) The proteasome prevents the expansion of
active chromatin regions at tissue-specific loci.
Tissue-specific gene loci contain early tran-
scription competence marks (ETCMs) in ES
cells that act as centers for transcription factor
recruitment. The 26S proteasome targets
cryptic promoter elements that are located outside of ETCMs to prevent nonspecific PIC assembly and spreading of the modified chromatin domain.
In differentiated cells, the recruitment of lineage-specific activators allows chromatin remodeling and stable PIC assembly at enhancers and pro-
moters, and the resulting PICs would no longer be susceptible to degradation by the 26S proteasome.Targeting of the Proteasome to Different
Types of Regulatory Elements
Amodel to explain the targeting of different subcomplexes
of the proteasome to specific regions in ES cells is shown
in Figure 7A. A central feature of the model is the presence
of two different types of preinitiation complex in the inter-
genic region. One type of PIC (PIC I) would be recruited to
the ETCM region by sequence-specific activators, where
it forms part of a center for recruitment of Pol II to the locus
(Szutorisz et al., 2005b). In addition to this, a second type
of PIC (PIC II) would form nonspecifically, leading to what
is termed permissive transcription. We propose that the
proteasome plays different roles in the assembly/disas-
sembly of these two types of PIC.
The analysis of binding of the Rpn12 lid subunit to the
l5-VpreB1 locus and the effect of Rpn12 knockdown on
transcription suggests that Rpn12 is involved in the regu-
lation of both specific and nonspecific PICs (Figure 7A,
PIC I and PIC II). In addition, the observation that Rpn12
recruitment depends on the presence of the Rpt3 ATPase
(Figure 5C) implies that Rpn12 is targeted to intergenic
elements as part of a 19S base-lid complex. Evidence for
differential targeting of proteasome subcomplexes comes
from two different observations. Firstly, an Rpn12-con-
taining 19S subcomplex binds to the ETCM region even
after RNAi-induced loss of core proteasome binding (Fig-
ures 4C, 5C, and 7A, PIC I). During recruitment of GTFs toCell 1the ETCM, this 19S subcomplex would have a chaperone
function as part of the activator-dependent PIC, similar to
the stimulatory role that has been described for the regu-
lation of gene transcription (Collins and Tansey, 2006).
Secondly, Rpn12 knockdown in ES cells abolishes target-
ing of the 20S core complex to the cryptic promoters and
blocks the suppressive effect of the proteasome on per-
missive transcription (Figures 4F and 7A, PIC II). The fact
that knockdown of subunits of the core, lid, and base
components of the proteasome all leads to increased in-
tergenic transcription is evidence that after recruitment
through different subcomplexes, the 19S and 20S parti-
cles are assembled into a functional 26S proteasome,
which removes PICs from the sites of permissive tran-
scription (Figure 7A, step 2, PIC II). However, the observa-
tion that the loss of Rpt3, an ATPase component of the
19S regulatory particle, does not abolish the recruitment
of the core proteasome subunit a4 (Figure 5C) suggests
that the 20S and 19S proteasome subcomplexes are re-
cruited separately to PICs that are targeted for degrada-
tion. In this respect, it is notable that several recent studies
have reported differential targeting of 19S and 20S protea-
somal subcomplexes to genomic regions in yeast (Auld
et al., 2006; Sikder et al., 2006) and human tumor cells
(Rasti et al., 2006).
A further unexpected finding from this study is the ob-
servation that Rpn12 and b6 occupancy in regulatory27, 1375–1388, December 29, 2006 ª2006 Elsevier Inc. 1385
regions is only detectable following chemical proteasome
inhibition. This could be due to (1) unstable binding of the
proteasome to ES cell chromatin or (2) differential acces-
sibility of the chromatin bound proteasome in the pres-
ence of the chemical inhibitor. The first explanation raises
the possibility of a dynamic autoregulatory mechanism.
The data suggest that some of the subunits or subcom-
plexes (the ones that contain b6 and Rpn12) bind only
transiently compared to others (e.g., a subcomplex con-
taining a4) and that the differential binding profile is linked
to the proteolytic activity of the proteasome (Figure 4B).
This can be explained by controlled cycles of assembly
and disassembly of the proteasome during the degrada-
tion of PIC components (Figure 7A, step 3, PIC II). A similar
mechanism has been described for the yeast 26S protea-
some in vitro, where ATP hydrolysis-dependent disas-
sembly of the 20S and19S particles occurs during each
proteolytic cycle (Babbitt et al., 2005). We cannot rule
out the alternative explanation that chemical inhibition
alters the conformation or the position of the chromatin
bound proteasome, thereby increasing the accessibility
of some epitopes for antibody recognition. However, it is
notable that knockdown of an ATPase component of the
base complex abolished Rpn12 and b6 binding after
chemical inhibition (Figure 5C), indicating that the dynamic
turnover of these subunits is linked to ATPase function
during proteolytic cycles. Taken together, our results sug-
gest that not only nonspecific PIC formation but also the
assembly of the proteasomes that target these PICs is
highly dynamic in ES cells.
Dynamic Turnover of Transcription Factor Binding
in ES Cells: A Role for the Proteasome
in Maintaining ES Cell Pluripotency
Our results raise interesting questions about the biological
significance of permissive transcription in ES cells and its
regulation at tissue-specific genes. It has been proposed
that low-level permissive transcription of lineage-specific
genes in stemcells helps to keep these genes in a dynamic
state, ready for activation at later stages (Meshorer and
Misteli, 2006). Our data indicate that there is a substantially
greater level of promoter activity in pluripotent stem cells
than had previously been detected but that transcription
is being suppressed by continuous removal of PICs from
cryptic promoters by the proteasome.
In the l5-VpreB1 locus, transcription from the normal
initiation sites of the genes is not induced by proteasome
inhibition, suggesting that activator-dependent gene pro-
moters are not preferred sites for initiation of permissive
transcription (Figure 7B). We find a striking clustering of
suppressed transcription start sites close to an enhancer
in the l5-VpreB1 locus (Figure 3A). This enhancer contains
a discrete region of active epigenetic modifications (the
ETCM). The active histone modifications have been
shown to spread from the ETCM into the region containing
the cryptic promoter as the cells commit to the B cell line-
age (Szutorisz et al., 2005a). A similar expansion of chro-1386 Cell 127, 1375–1388, December 29, 2006 ª2006 Elseviermatin modification and factor binding has been observed
during the developmental activation of the b-globin,
HoxD4, and other tissue-specific loci (Bulger, 2005). Our
observation that binding of components of chromatin-
modifying complexes (Brg1 and TRRAP) is restricted by
the proteolytic activity of the proteasome (Figure 3) sug-
gest a potential mechanism by which the proteasome
could prevent the spread of modified, active chromatin
in ES cells.
The silencing of nonspecific transcription by the protea-
some adds a new dimension to the control of ES cell plu-
ripotency. The results presented in this study suggest that
lineage-specific gene loci are in a highly dynamic state in
ES cells with factors continuously binding to regulatory
sequences and being removed by the proteasome. This
control is likely to have the effect of keeping tissue-
specific genes in a transcriptionally competent state,
ready for activation as the cells differentiate into various
lineages.
EXPERIMENTAL PROCEDURES
A detailed version of the experimental procedures can be found in the
Supplemental Data.
Cell Culture and Inhibitor Treatments
Mouse E14 ES cell, Pre-B cell, and mature B cell cultures were estab-
lished and maintained as described in Szutorisz et al. (2005a). Cells
were treated in culture media with 20 mM MG132 (Sigma), 10 mM lac-
tacystine (Calbiochem), 1 mM leupeptin (Sigma), and 20 mMammonium
chloride for the indicated length of time. The condition of the cells was
monitored by propidium-iodide- (PI) staining followed by FACS analy-
sis (Figure S1).
RNAi Knockdown in ES Cells
The following siRNAs were purchased from Ambion: b4 (ID no. 70480),
b7 (ID no. 164718), Rpn12 (ID no. 183824), Rpt3 (ID no. 187917), pos-
itive control for GAPDH, and negative control nonsilencing siRNA.
Feeder-free ES cells were transfected with 125 pmole siRNA using
the protocol described in the Supplemental Data.
RNA Analysis
Quantitative reverse-transcription PCR (Q-RT-PCR) and rapid amplifi-
cation of cDNA ends (RACE) were performed as described in the
Supplemental Data.
ChIP
Fixed chromatin preparation and ChIP are described in Szutorisz et al.
(2005a). ChIP analysis following siRNA knockdown of proteasome
subunits is described in the Supplemental Data. Protein binding in
untreated cells is shown as a ratio relative to background (obtained
using nonspecific antibodies and without antibody). Changes in bind-
ing following proteasome inhibition are expressed as ratios between
normalized ChIP signals (compared to background, as above) from
inhibitor-treated and untreated cells.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, and six figures and can be found with this
article online at http://www.cell.com/cgi/content/full/127/7/1375/
DC1/.Inc.
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